SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Bishop who wrote ()6/16/2000 11:45:00 AM
From: Wayne Rumball   of 150070
 
AIDS, Cancer, MS, these boys think they can cure it all;
HOUSTON, June 16 /PRNewswire/ -- Pathobiotek Diagnostics Inc.
(OTC Bulletin Board: PBTK) (http://www.pathobiotek.com), a developer of
products for the diagnosis and evaluation of treatment for multiple sclerosis
(MS) and other immune disorders, announced the receipt of the "Certificate of
Allowability" for the patent. The actual issuance of the patent is now a
formality, which will occur within a few days after the paperwork is returned
to the patent office.
The company's investigations have demonstrated that the Activating Virus
(AV) is a novel virus found in humans with a variety of cancers and
immunosuppressive diseases plus marmosets with wasting syndrome. Wasting
syndrome in marmosets resembles AIDS in humans. AV is associated with
cancerous cell lines and may be a cofactor in human tumors. Studies to
further characterize the genetic composition of this virus are ongoing.
The commercial value of this patent has enormous upside potential and
could be of significant financial benefit to Pathobiotek.
Additional information on Pathobiotek Diagnostics Inc. can be obtained at
pathobiotek.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News